Eloxatin Plus Gemcitabine Chemotherapy for Mesothelioma

Get Help Today

Looking for help or additional information? Contact us today.
First Name:
Last Name:
Email:
Phone:
Zip Code:
Comments:
Please enter the number below:
3370
Conditions: Mesothelioma
Start Date: April 1, 2004
Phase: Phase II
Status: Active, not recruiting
NCT ID: NCT00859469
Study Type: Interventional
Intervention: Drug: Oxaliplatin/Gemcitabine
Study Design: Allocation: Non-Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment
Results: No Results Available
Sponsors: Columbia University
Ages: Adult|Senior
Enrollment: 29
Funded By: Other
First Received: March 9, 2009
End Date: April 1, 2011
Last Updated: January 12, 2011
Last Verified: January 1, 2011